Pharming Group NV (PHAR)
11.79
-0.11
(-0.92%)
USD |
NASDAQ |
Oct 27, 16:00
11.89
+0.10
(+0.85%)
After-Hours: 20:00
Pharming Group Market Cap : 834.47M for Oct. 27, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 26, 2026 | 842.26M |
| October 23, 2026 | 792.71M |
| October 22, 2026 | 755.20M |
| October 21, 2026 | 683.01M |
| October 20, 2026 | 690.09M |
| October 19, 2026 | 644.79M |
| October 16, 2026 | 662.48M |
| October 15, 2026 | 681.59M |
| October 14, 2026 | 682.30M |
| October 13, 2026 | 668.15M |
| October 12, 2026 | 680.18M |
| October 09, 2026 | 692.92M |
| October 08, 2026 | 674.52M |
| October 07, 2026 | 683.01M |
| October 06, 2026 | 685.13M |
| October 05, 2026 | 693.63M |
| October 02, 2026 | 690.09M |
| October 01, 2026 | 704.24M |
| September 30, 2026 | 707.07M |
| September 29, 2026 | 708.49M |
| September 28, 2026 | 744.59M |
| September 25, 2026 | 740.34M |
| September 24, 2026 | 738.92M |
| September 23, 2026 | 762.28M |
| September 22, 2026 | 796.96M |
| Date | Value |
|---|---|
| September 21, 2026 | 765.11M |
| September 18, 2026 | 746.71M |
| September 17, 2026 | 762.99M |
| September 16, 2026 | 750.25M |
| September 15, 2026 | 746.71M |
| September 14, 2026 | 765.82M |
| September 11, 2026 | 793.42M |
| September 10, 2026 | 764.76M |
| September 09, 2026 | 776.44M |
| September 08, 2026 | 813.95M |
| September 04, 2026 | 794.84M |
| September 03, 2026 | 811.12M |
| September 02, 2026 | 792.71M |
| September 01, 2026 | 786.34M |
| August 31, 2026 | 812.53M |
| August 28, 2026 | 828.10M |
| August 27, 2026 | 833.77M |
| August 26, 2026 | 845.80M |
| August 25, 2026 | 833.06M |
| August 24, 2026 | 811.12M |
| August 21, 2026 | 838.72M |
| August 20, 2026 | 826.69M |
| August 19, 2026 | 838.72M |
| August 18, 2026 | 842.97M |
| August 17, 2026 | 834.47M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| ProQR Therapeutics NV | 188.40M |
| NewAmsterdam Pharma Co. NV | 2.412B |
| argenx SE | 54.61B |
| Nektar Therapeutics | 1.296B |
| uniQure NV | 1.683B |
Market Cap Related Metrics
| PE Ratio | 94.85 |
| PS Ratio | 2.370 |
| Price to Book Value | 3.247 |
| Price to Free Cash Flow | 33.78 |
| Price | 11.79 |
| Earnings Yield | 1.05% |
| Operating PE Ratio | 38.83 |
| Normalized PE Ratio | 52.92 |